Immunohistochemical analysis of PEDF expression in human neoplasms revealed that an increase in PEDF expression correlates with a better prognosis, which supports the idea that the determination of PEDF might be a prognostic factor in the treatment of cancer. The gene discussed is SERPINF1; the disease is neoplasm.